Skip to main content
. 2020 Apr 18;18(8):1753–1759.e2. doi: 10.1016/j.cgh.2020.04.030

Table 2.

Laboratory Findings of 84 Patients Infected With SARS-CoV-2 on Admission to Hospital

All patients (n = 84) Diarrhea group (n = 26) Non-diarrhea group (n = 58) P value
White blood cell count, ×109/L 4.0 ± 1.5 3.7 ± 1.6 4.2 ± 1.5 .170
 <3.5, n (%) 36 (43) 16 (62) 20 (35) .055
 3.5–9.5, n (%) 46 (55) 10 (38) 36 (62)
 >9.5, n (%) 2 (2) 0 (0) 2 (3)
Neutrophil count, ×109/L 2.4 ± 1.1 2.3 ± 1.3 2.5 ± 1.0 .443
Lymphocyte count, ×109/L 1.3 ± 0.6 1.1 ± 0.4 1.3 ± 0.7 .178
 <1.1, n (%) 33 (39) 14 (54) 19 (33) .143
 1.1–3.2, n (%) 49 (58) 12 (46) 37 (64)
 >3.2, n (%) 2 (2) 0 2 (3)
Platelet count, ×109/L 180.1 ± 58.2 164.6 ± 55.4 187.1 ± 58.8 .103
Hemoglobin, g/L 128.3 ± 15.6 128.8 ± 15.5 128.1 ± 15.8 .851
ALT, U/L 28.3 ± 19.3 20.6 ± 7.5 31.6 ± 21.8 .014
AST, U/L 29.0 ± 13.1 24.9 ± 6.4 30.8 ± 14.8 .055
ALB, g/L 40.4 ± 4.1 40.5 ± 4.7 40.3 ± 3.8 .837
T-BIL, μmol/L 9.2 ± 3.0 8.3 ± 2.4 9.7 ± 3.2 .050
D-BIL, μmol/L 3.0 ± 2.2 2.5 ± 1.5 3.2 ± 2.4 .175
CREA, μmol/L 69.0 ± 18.9 66.4 ± 15.5 70.1 ± 20.3 .411
BUN, mmol/L 3.7 ± 1.3 3.6 ± 1.3 3.8 ± 1.3 .516
CK, U/L 109.5 ± 149.3 72.9 ± 45.3 125.9 ± 175.4 .134
LDH, U/L 238.1 ± 98.5 213.1 ± 49.6 249.3 ± 112.6 .121
PT, sec 13.3 ± 1.5 13.8 ± 2.6 13.1 ± 0.5 .051
APTT, sec 38.8 ± 3.5 38.8 ± 4.2 38.7 ± 3.2 .905
D-dimer, mg/L 0.47 ± 0.41 0.49 ± 0.51 0.46 ± 0.36 .758
CRP, mg/L, n (%)
 <8.0 35 (42) 9 (35) 26 (45) .475
 ≥8.0 49 (58) 17 (65) 32 (55)
PCT, μg/L, n (%)
 <0.5 82 (98) 25 (96) 57 (98) .526
 ≥0.5 2 (2) 1 (4) 1 (2)
ESR, mm/h 21.9 ± 18.7 19.2 ± 14.1 23.0 ± 20.3 .390

ALB, albumin; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CK, creatine kinase; CREA, creatinine; CRP, C-reactive protein; D-BIL, direct bilirubin; ESR, erythrocyte sedimentation rate; LDH, lactic dehydrogenase; PCT, procalcitonin; PT, prothrombin time; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; T-BIL, total bilirubin.